Compound Management & Integrity conference to address challenges in improvement methodologies

An efficient and versatile compound management operation is essential for the success of all downstream processes in high throughput screening (HTS) and small molecule development. The 6^th Compound Management & Integrity conference taking place September 20 - 22, 2010 will address issues concerned with improving both strategic and tactical aspects of compound management.

Topics to be discussed at the event include:

• Leveraging best in class methodologies to improve quality control and compound purity
• Apply acoustic dispensing as a way to avoid the drawbacks of undesired physical contact with the same sample
• Support both HTS and multiple hit strategies with flexible processes to increase quality, performance and capability

Participating organizations include Pfizer, Merck, AstraZeneca, GlaxoSmithKline, Johnson &Johnson, Biogen, Sanofi-Aventis, The Scripps Research Institute and more.

Attendees at this event will consist of compound management, sample management, compound library, lead generation, high throughput screening, assay development, pharmacokinetics, informatics, drug delivery, automation and process co-ordination.